A Study of Romosozumab in Women With Multiple Myeloma and Osteoporosis
Clinical trial NCT05775094 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05775094
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-07
- Primary completion
- 2027-03-01
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.